View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Johnson & Johnson: Update following ratings affirmation

Our credit view of this issuer reflects its strong global scale and diversity and conservative financial policies, offset by unresolved talc litigation exposures.

Moody's Ratings affirms J&J's Aaa ratings; stable outlook

Moody's Ratings (Moody's) affirmed the ratings of Johnson & Johnson ("J&J") including the Aaa long-term issuer rating, Aaa senior unsecured rating, (P)Aaa senior unsecured medium term note program rating and Prime-1 commercial paper rating. The outlook remains stable. This rating action follows th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Johnson & Johnson: 1 director

A director at Johnson & Johnson sold 8,891 shares at 162.160USD and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Merck & Co Inc: 2 directors

Two Directors at Merck & Co Inc sold after exercising options/sold 100,193 shares at between 126.649USD and 126.968USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all t...

MarketLine Department
  • MarketLine Department

Saponia dd - Company Profile and SWOT Analysis

Summary Saponia dd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Saponia dd (Saponia) is a manufacturer of home care and personal hygiene products. The company’s product portfolio comprises dish detergents, laundry detergents, toothbrushes, baby care, hand cream, shaving ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Johnson & Johnson: Solid operating performance and pipeline execution,...

Our credit view of this issuer reflects its strong scale, diversity, profit margins and cash flow, offset by unresolved legal exposures and event risk associated with acquisitions.

Johnson & Johnson - July 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's: New setback in J&J talc litigation raises uncertainty

Moody's Investors Service commented that the recent setback in Johnson & Johnson's (Aaa stable) efforts to resolve outstanding talc litigation is credit negative. A federal judge dismissed the bankruptcy filing by J&J's subsidiary LTL Management LLC (LTL). This process would significantly reduce the...

Johnson & Johnson: New setback in talc litigation raises uncertainty

J&J is appealing the dismissal of the LTL bankruptcy filing, but is prepared to continue working with talc plaintiffs or otherwise return to the tort system, raising uncertainty

Johnson & Johnson - April 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

VRS RESEARCH TEAM
  • VRS RESEARCH TEAM

JOHNSON & JOHNSON Flash Note

Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being.

Moody's assigns A1 rating to Merck's sr. notes; stable outlook

Moody's Investors Service ("Moody's") assigned an A1 rating to the new senior unsecured notes offering of Merck & Co., Inc. ("Merck"). There are no changes to Merck's existing ratings including the A1 senior unsecured long-term rating or the Prime-1 short-term rating. The outlook remains stable. ...

Johnson & Johnson: Solid operating performance, while resolution of ta...

Our credit view of this issuer reflects its strong scale and diversity and conservative financial policies, tempered by unresolved litigation risks including talc product safety

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch